Chromocell Therapeutics Corporation (CHRO) — Tangible Net Worth Ratio
Chromocell Therapeutics Corporation (CHRO) has a Tangible Net Worth Ratio of 100.0% as of March 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.13 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. For live market cap and overall valuation, see CHRO market cap overview.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Annual Tangible Net Worth Ratio for Chromocell Therapeutics Corporation (None–None)
The table below presents the year-by-year Tangible Net Worth Ratio for Chromocell Therapeutics Corporation from None to None, covering 0 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See CHRO financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|